Profil
Zhen Ping Zhu is the founder of Earendil Labs, Inc., founded in 2024, serving as President & Co-Chief Executive Officer.
The current job is Director at Numab Therapeutics AG since 2018.
Former jobs include Director & Deputy General Manager at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. from 2019 to 2022; Director at Refuge Biotechnologies, Inc.; Chief Scientific Officer & President-Research at 3SBio, Inc. from 2017 to 2019; Executive Vice President-Biologics at Kadmon Holdings, Inc.; EVP-Global Biologics Research & Development at Kadmon Pharmaceuticals LLC; Executive Vice President-Global Biopharmaceuticals at Kadmon Corp.
LLC from 2010 to 2016; and Vice President at ImClone Systems LLC.
Education includes a doctorate from Dalhousie University, a doctorate from Jiangxi Medical College, graduate studies at Chinese Academy of Medical Sciences, and graduate studies at Peking Union Medical College.
Postes actifs de Zhen Ping Zhu
| Sociétés | Poste | Début |
|---|---|---|
Numab Therapeutics AG
Numab Therapeutics AG BiotechnologyHealth Technology Develops antibody-based immunotherapies for inflammation and cancer | Directeur/Membre du Conseil | 01/03/2018 |
Anciens postes connus de Zhen Ping Zhu
| Sociétés | Poste | Fin |
|---|---|---|
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Directeur Technique/Scientifique/R&D | 13/01/2022 |
| 3SBIO INC. | Directeur Technique/Scientifique/R&D | 01/09/2019 |
| KADMON HOLDINGS, INC. | Corporate Officer/Principal | 06/01/2017 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Directeur/Membre du Conseil | - |
Formation de Zhen Ping Zhu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
3SBio, Inc.
3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Dalhousie University
Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangxi Medical College
Jiangxi Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Medical Sciences
Chinese Academy of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Peking Union Medical College
Peking Union Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Numab Therapeutics AG
Numab Therapeutics AG BiotechnologyHealth Technology Develops antibody-based immunotherapies for inflammation and cancer | Health Technology |
ImClone Systems LLC
ImClone Systems LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Commercial Services |
















